findmyKOL

Celso Velazquez, MD

Basic profile

University of Missouri

ORCIDNone on fileNPI
RegionColumbia, MO · MidwestSpecialtyRheumatologyFocusRheumatology/Immunology
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Celso Velazquez is a Rheumatology/Immunology physician affiliated with University of Missouri. OpenAlex indexes 16 publications with 237 citations (h-index 6).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

237citations

Total citations across indexed works.

6h-index

Hirsch index, productivity × impact (OpenAlex).

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    40%
    TNF inhibitor12.4%
    Humira(Cf) Pen58%Enbrel15%Cimzia10%Humira Pen10%Humira(Cf)7%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor10.6%
    Methotrexate100%
    Part D36 patients

    + 7 more classes in this area

  • Nervous system

    29.1%
    Gabapentinoids16.8%
    Pregabalin86%Gabapentin14%
    Part D<11 patients
    Opioid Agonist10.9%
    Tramadol Hcl79%Oxycodone-Acetaminophen14%Oxycodone Hcl7%
    Part D<11 patients

    + 1 more class in this area

  • Antiparasitic

    12.4%
    Antimalarial12.4%
    Hydroxychloroquine Sulfate100%
    Part D54 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

10 more publications behind the reveal.Reveal →

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”